Previous studies have suggested that therapeutic intervention with a DPP-4 inhibitor is effective in postponing the development of neuropathy, cardiovascular disease, and diabetic nephropathy [25,35,43,44]. The gene discussed is DPP4; the disease is diabetic kidney disease.